A journal has retracted a meta-analysis on Covid-19 after concerned readers complained about the quality — or lack thereof — of the study.
The article, “A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients,” appeared in Therapeutic Advances in Chronic Disease, a SAGE title.
According to the retraction notice:
Continue reading Authors retract, resubmit “very poorly conducted” meta-analysis of COVID-19 treatment
A leading heart journal has issued an expression of concern for a meeting abstract it published earlier this year by a cardiac surgeon who sells dietary supplements of questionable utility.
The case is the second involving a recent meeting of the American Heart Association.
The abstract, titled “Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning,” was presented at the AHA’s 2021 Scientific Sessions in mid-November and was published in Circulation.
The author was Steven Gundry, a cardiac surgeon by training who now sells dietary supplements on his website. Gundry also sees patients at the Center for Restorative Medicine and International Heart & Lung Institute in California and offers advice on YouTube.
But critics have accused Gundry of peddling worthless — if ultimately expensive — advice.
Continue reading Abstract linking COVID-19 vaccines to heart trouble risk earns expression of concernA psychiatry journal has retracted two papers on Covid-19 and mental health, and a third on racism, after concluding that an author on the articles rigged the peer-review process.
The papers, which appeared in the International Journal of Social Psychiatry (IJSP), were co-authored by Debanjan Banerjee, then geriactric psychiatrist at the National Institute of Mental Health and Neurosciences in Bengaluru, and his colleagues.
Banerjee, who has since left the institution, was also until recently a “trainee editor” at the journal, as Neuroskeptic noted on Twitter last week, as well as an associate editor of the Journal of Psychosexual Health — both of which are SAGE titles. He’s also an associate editor for the Frontiers journal Aging Psychiatry.
According to the IJSP:
Continue reading Journal retracts three papers — including two on COVID-19 — because ‘trainee editor’ committed misconduct
A former graduate student at Georgia Tech who at least until recently worked at Shell confessed last year to misconduct in three published papers.
Michael Casciato, who earned his doctorate from Georgia Tech in 2013, wrote in a June 22, 2020 email to the editor of an American Chemical Society journal as well as the principal investigator of the lab where he completed his PhD, Martha Grover, and a co-author, Dennis Hess:
Continue reading Exclusive: Shell employee confesses to graduate student misdeeds
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.
The week at Retraction Watch featured:
Our list of retracted or withdrawn COVID-19 papers is up to 192. There are now more than 31,000 retractions in our database — which now powers retraction alerts in EndNote, Papers, and Zotero. And have you seen our leaderboard of authors with the most retractions lately?
Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):
Continue reading Weekend reads: Nepotism in journals; the lessons of the ‘lab leak’ theory; four decades of research misconduct
Researchers in the United States and Singapore have lost a 2016 article in Science Advances after some of the group learned that one of their colleagues appears to have used duplicated images in the work.
The article, “A universal cooperative assembly-directed method for coating of mesoporous TiO2 nanoshells with enhanced lithium storage properties,” was written by Bu Yuan Guan, then of the School of Chemical and Biomedical Engineering, Nanyang Technological University, along with colleagues at that institution and Ju Li, of the Department of Nuclear Science and Engineering and the Department of Materials Science and Engineering at the Massachusetts Institute of Technology.
The paper has been cited 167 times, according to Clarivate Analytics’ Web of Science.
According to the retraction notice:
Continue reading Nanotech paper retracted for duplicated imagesA group of researchers in Egypt have lost a second paper on possible treatments for Covid-19 after questions were raised about the legitimacy of their trial findings — and additional retractions might be coming soon.
As we reported in September, the group lost an article in Scientific Reports about a purported trial comparing favipiravir and hydroxychloroquine to treat the infection.
That move followed an expression of concern, issued in early August, for a paper in the Archives of Virology by Dabbous and his colleagues about favipiravir, titled “Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.”
The journal has now retracted the article:
Continue reading Group’s second paper on potential treatments for COVID-19 is retracted
The University of Glasgow is “in discussions to retract” seven papers by a pharmacology researcher who worked there for more than 25 years, after it learned of allegations on PubPeer by pseudonymous whistleblower Clare Francis.
The development confirms reporting by Retraction Watch earlier this month. In that post, we wrote:
Continue reading University of Glasgow ‘in discussions to retract’ seven papers, confirming Retraction Watch reporting
A cancer immunologist who as of 2017 was “the most highly cited immunologist in Australia” has “seriously breached Codes relating to responsible research conduct,” according to his former employer.
QIMR Berghofer in Brisbane “has commissioned an independent external investigation after a number of complaints relating to the research conduct of a former employee Professor Mark Smyth,” the institute said in a statement.
The external investigation, led by a retired appeals court judge, Robert Gotterson, followed a preliminary investigation, according to QIMR Berghofer, which said it “has referred the findings to the Crime and Corruption Commission in accordance with its legislative obligations.” The institute has “also organised for an independent review into a broad range of issues arising out of the Panel Report” that will be conducted by former federal court judge Bruce Lander.
Continue reading Highly cited cancer immunologist “seriously breached” research conduct code: Australia institute
A journal is considering issuing an expression of concern for a 2005 paper by authors tied to a company that’s now under investigation for fraud, Retraction Watch has learned.
[See an update on this post (bottom).]
The article, “Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor–G protein coupling and Gβγ signaling,” was written by a group linked to Pain Therapeutics, Inc., which in 2019 changed its name to Cassava Sciences.
Last week, the Wall Street Journal reported that the U.S. Securities and Exchange Commission and the National Institutes of Health were investigating claims that the company manipulated data for simulfilam, its experimental drug for Alzheimer’s disease.
As we reported in August, a law firm submitted a “citizen’s petition” to the FDA citing:
Continue reading Journal mulls expression of concern for Cassava Sciences paper